We are live on ! Find out more
AGN.PRA

Allergan plc

Delisted

AGN.PRA was delisted on the 28th of February, 2018.

99 hedge funds and large institutions have $3.92B invested in Allergan plc in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

178% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 9

35% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 23

29% more funds holding in top 10

Funds holding in top 10: 79 (+2)

24% more capital invested

Capital invested by funds: $3.17B → $3.92B (+$752M)

18% more funds holding

Funds holding: 8499 (+15)

Holders
99
Holders Change
+15
Holders Change %
+17.86%
% of All Funds
2.76%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.25%
New
25
Increased
31
Reduced
23
Closed
9
Calls
Puts
Net Calls
Net Calls Change

AGN.PRA Hedge Fund Activity: Q3 2015 in Review

99 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN.PRA) for Q3 2015, worth a combined $3.92B — up 24% from $3.17B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new AGN.PRA positions and 9 closed out — a net gain of 16 holders — while 31 added to existing stakes and 23 trimmed.

The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $424M. The largest seller was Kingdon Capital Management, cutting an estimated $21.4M.

  • 99 institutional investors held Allergan plc (AGN.PRA) as of Q3 2015, up from 84 in Q2 2015.
  • Funds reported $3.92B of Allergan plc stock for Q3 2015, up 24% quarter-over-quarter.
  • 25 funds opened new Allergan plc positions in Q3 2015 and 9 closed out, a net change of +16 holders.
  • The largest Allergan plc buyer in Q3 2015 was BlackRock Fund Advisors, an estimated $424M added.
  • The largest Allergan plc seller in Q3 2015 was Kingdon Capital Management, an estimated $21.4M sold.

Based on aggregated 13F filings for Q3 2015.